Views & Analysis Saving the jewel in the crown of ‘UKplc’: Brexit's impact on... Pharma must embrace the opportunity to shape the UK’s political agenda in its favour.
News Disappointment for UK pharma as Life Sciences minister role ... No successor for Freeman, but Office for Life Sciences to remain
News GSK shows confidence in Brexit Britain with manufacturing in... GSK confident in UK despite Brexit.
News Pharma faces pressure whoever wins Presidential race, warns ... Novartis chief warns on US pricing pressure
News George Freeman promoted, leaving Life Science minister role ... Life Science minister post set to be scrapped
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
